Nordson (NDSN) Investor presentation summary

Business overview and growth strategy

• Operates in over 35 countries with $2.8B revenue and 32% EBITDA margin in 2025.

• Focuses on diversified end markets: electronics (27%), medical (25%), consumer non-durable (23%), and industrial (13%).

• Three main segments: Industrial Precision Solutions (48% of revenue), Medical Fluid Solutions (30%), and Advanced Technology Solutions (22%).

• High recurring sales from parts and consumables (60% of revenue).

• Growth driven by product innovation, disciplined M&A, and a division-led, entrepreneurial culture.

Financial performance and targets

• 2025 revenue reached $2.8B with 32% EBITDA margin and 62 consecutive years of dividend increases.

• 2025-2029 targets: 6-8% annual revenue growth, 10-12% adjusted EPS growth.

• Q1 2026 sales grew 9% to $669M, with 7% organic growth and 8% EBITDA increase to $203M.

• Free cash flow conversion exceeded 100% for three consecutive quarters.

• 2026 full-year guidance raised: sales growth 3-7% YOY, adjusted EPS $11.00-$11.60.

Segment highlights and market trends

• IPS: $1.3B revenue in 2025, serving packaging, industrial, and consumer markets; focus on EV, solar, and process innovation.

• MFS: $835M revenue, strong in single-use medical components and surgical solutions; 8% 5-year sales CAGR.

• ATS: $625M revenue, 9% 5-year sales CAGR, focused on semiconductors, electronics, and automotive; margin expansion via NBS Next.

• End markets show varying growth rates: medical (5-8%+), semiconductors (6-8%), industrial (1-4%).